Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Beteiligte Einrichtungen
Abstract
Two HCV antibody tests (EIA 2.0 [EIA2], Abbott; and the Version 3.0 ELISA [EIA3], Ortho) are currently licensed for screening of US blood donors. Testing of donors for HCV RNA allows comparison of the sensitivities of the two antibody-screening assays.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 11 |
| ISSN | 0041-1132 |
| Status | Veröffentlicht - 2002 |
| pubmed | 12421226 |
|---|
